المؤلفون: Coward JIG, Middleton K, Murphy F

المصدر: International Journal of Women's Health, Vol 2015, Iss default, Pp 189-203 (2015)

مصطلحات موضوعية: Gynecology and obstetrics, RG1-991

وصف الملف: electronic resource

Relation: http://www.dovepress.com/new-perspectives-on-targeted-therapy-in-ovarian-cancer-peer-reviewed-article-IJWH; https://doaj.org/toc/1179-1411

URL الوصول: https://doaj.org/article/09cb1eed56cb4202b9b8b258f77d4bbc

المؤلفون: Frentzas S; Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia., Austria Mislang AR; Icon (Adelaide) Cancer Centre, Kurralta Park, South Australia, Australia.; Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia., Lemech C; Scientia Clinical Research Ltd, Sydney, New South Wales, Australia., Nagrial A; Blacktown Cancer and Haematology Centre, Blacktown Hospital, University of Sydney, Sydney, New South Wales, Australia., Underhill C; Border Medical Oncology and Haematology Research Unit, Albury-Wodonga Regional Cancer Centre, Albury Wodonga, New South Wales, Australia.; University of New South Wales, Rural Medical School, Albury Campus, Sydney, New South Wales, Australia., Wang W; Akeso Biopharma, Inc, Zhongshan, China., Wang ZM; Akeso Biopharma, Inc, Zhongshan, China., Li B; Akeso Biopharma, Inc, Zhongshan, China., Xia Y; Akeso Biopharma, Inc, Zhongshan, China., Coward JIG; Icon Cancer Centre, Brisbane, Queensland, Australia jim.coward@icon.team.; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 19; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 19.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/adverse effects , Neoplasms*/drug therapy, Humans ; Antibodies, Monoclonal, Humanized/adverse effects ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Hypertension/chemically induced ; Immune Checkpoint Inhibitors/therapeutic use ; Lung Neoplasms/drug therapy ; Programmed Cell Death 1 Receptor/therapeutic use ; Tumor Microenvironment ; Vascular Endothelial Growth Factor A

المؤلفون: Malczewski AB; Icon Cancer Centre, Wesley, Brisbane, QLD, Australia.; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.; Science and Technology, University of New England, Armidale, NSW, Australia., Ketheesan N; Science and Technology, University of New England, Armidale, NSW, Australia., Coward JIG; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.; Icon Cancer Centre, South Brisbane, Brisbane, QLD, Australia., Navarro S; Department of Immunology, QIMR Berghofer, Brisbane, QLD, Australia.; Woolworths Centre for Childhood Nutrition Research, Faculty of Health, Queensland University of Technology, South Brisbane, QLD, Australia.

المصدر: Frontiers in immunology [Front Immunol] 2021 Jul 07; Vol. 12, pp. 624434. Date of Electronic Publication: 2021 Jul 07 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Diet/*methods , Gastrointestinal Microbiome/*drug effects , Immune Checkpoint Inhibitors/*therapeutic use , Metabolome/*immunology , Neoplasms/*drug therapy, Animals ; Bacteria/metabolism ; Diet/adverse effects ; Dysbiosis/complications ; Gastrointestinal Microbiome/immunology ; Humans ; Immunomodulation ; Life Style ; Metabolome/drug effects ; Mice ; Neoplasms/immunology

المؤلفون: Guazzo E; Department of Otolaryngology, Head and Neck Surgery, Princess Alexandra Hospital, Brisbane, Australia., Cooper C; Pathology Queensland, Princess Alexandra Hospital, Brisbane, Australia., Wilkinson L; Sullivan and Nicolaides Pathology, Brisbane, Australia., Feng S; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia., King B; The University of Queensland Diamantina Institute, Princess Alexandra Hospital University of Queensland, Brisbane, Australia., Simpson F; The University of Queensland Diamantina Institute, Princess Alexandra Hospital University of Queensland, Brisbane, Australia., Porceddu S; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Australia., Panizza B; Department of Otolaryngology, Head and Neck Surgery, Princess Alexandra Hospital, Brisbane, Australia.; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Australia., Coward JIG; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Australia.; ICON Cancer Centre, Level 5, Mater Medical Centre, Brisbane, Australia.

المصدر: Head & neck [Head Neck] 2021 Mar; Vol. 43 (3), pp. 768-777. Date of Electronic Publication: 2020 Nov 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*/genetics , Carcinoma*, B7-H1 Antigen/genetics ; ErbB Receptors/genetics ; Humans ; Retrospective Studies ; Salivary Glands

المؤلفون: Nguyen THM; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Carreira PE; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Sanchez-Luque FJ; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia; Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research, PT Ciencias de la Salud, Granada 18016, Spain., Schauer SN; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Fagg AC; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Richardson SR; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Davies CM; Mater Health Services, South Brisbane, QLD 4101, Australia., Jesuadian JS; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Kempen MHC; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Troskie RL; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., James C; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Beaven EA; Mater Health Services, South Brisbane, QLD 4101, Australia., Wallis TP; Mater Health Services, South Brisbane, QLD 4101, Australia., Coward JIG; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia; Mater Health Services, South Brisbane, QLD 4101, Australia., Chetty NP; Mater Health Services, South Brisbane, QLD 4101, Australia., Crandon AJ; Mater Health Services, South Brisbane, QLD 4101, Australia., Venter DJ; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia; Mater Health Services, South Brisbane, QLD 4101, Australia., Armes JE; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia; Mater Health Services, South Brisbane, QLD 4101, Australia., Perrin LC; Mater Health Services, South Brisbane, QLD 4101, Australia., Hooper JD; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Ewing AD; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia., Upton KR; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: k.upton@uq.edu.au., Faulkner GJ; Mater Research Institute, University of Queensland, TRI Building, Woolloongabba, QLD 4102, Australia; Queensland Brain Institute, University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: faulknergj@gmail.com.

المصدر: Cell reports [Cell Rep] 2018 Jun 26; Vol. 23 (13), pp. 3730-3740.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Evolution, Molecular*, Long Interspersed Nucleotide Elements/*genetics , Ovarian Neoplasms/*pathology, Antineoplastic Agents/therapeutic use ; Cell Line, Tumor ; DNA Methylation ; Drug Resistance, Neoplasm ; Female ; Gene Expression Regulation, Neoplastic ; Glycoproteins/genetics ; Glycoproteins/metabolism ; Humans ; Loss of Heterozygosity/genetics ; Mutagenesis, Insertional ; Mutation ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics

المؤلفون: Makarious D; Bond University, School of Medicine, Robina, Australia., Horwood K; ICON Cancer Care, Brisbane, Australia., Coward JIG; ICON Cancer Care, Brisbane, Australia; Faculty of Medicine, University of Queensland, Australia; Princess Alexandra Hospital, Brisbane, Australia. Electronic address: jim.coward@gmail.com.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Sep; Vol. 82, pp. 128-136. Date of Electronic Publication: 2017 Jun 27.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Immunotherapy/*adverse effects , Myasthenia Gravis/*chemically induced, Aged, 80 and over ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects ; B7-H1 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/antagonists & inhibitors ; Female ; Humans ; Ipilimumab ; Nivolumab